Skip to main navigation Skip to search Skip to main content

Using baseline MRI radiomic features to predict the efficacy of repetitive transcranial magnetic stimulation in Alzheimer’s patients

Research output: Contribution to journal › Article › Research › peer-review

Abstract

The efficacy of repetitive transcranial magnetic stimulation (rTMS) as a treatment for Alzheimer’s disease (AD) is uncertain at baseline. Herein, we aimed to investigate whether radiomic features from the pre-treatment MRI data could predict rTMS efficacy for AD treatment. Out of 110 participants with AD in the active (n = 75) and sham (n = 35) rTMS treatment groups having T1-weighted brain MRI data, we had two groups of responders (active = 55 and sham = 24) and non-responders (active = 20 and sham = 11). We extracted histogram-based radiomic features from MRI data using 3D Slicer software; the most important features were selected utilizing a combination of a two-sample t-test, correlation test, least absolute shrinkage, and selection operator. The support vector machine classified rTMS responders and non-responders with a cross-validated mean accuracy/AUC of 81.9%/90.0% in the active group and 87.4%/95.8% in the sham group. Further, the radiomic features of the active group significantly correlated with participants’ AD assessment scale-cognitive subscale (ADAS-Cog) change after treatment (false discovery rate corrected p < 0.05). Given that baseline radiomic features were able to accurately predict AD patients’ responses to rTMS treatment, these radiomic features warrant further investigation for personalizing AD therapeutic strategies.

Original languageEnglish
Pages (from-to)2943–2953
Number of pages11
JournalMedical and Biological Engineering and Computing
Volume63
DOIs
Publication statusPublished - 2025
Externally publishedYes

Keywords

  • Alzheimer’s disease
  • Efficacy prediction
  • Magnetic resonance imaging
  • Radiomic features
  • Repetitive transcranial magnetic stimulation

Cite this